Childhood Cancers | Tumor

CURE’s childhood cancers page is a go-to resource for oncology news and updates in the world of childhood cancers Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in childhood cancers.

FDA Approves Imbruvica for Potentially Serious Complication in Children With Cancer

August 24th 2022, 8:12pm

Article

The FDA approved Imbruvica for children over the age of 1 who are experiencing chronic GVHD that has already been treated by one or more prior therapy.

Childhood Cancer Survivors Are at an Increased Risk for Hospitalization Due to Infection Several Years After Treatment Has Ended

August 4th 2022, 1:00pm

Article

Survivors of childhood cancer had higher rates of infection-related hospitalizations than their healthy peers, at both the five- and 10-year post-treatment mark.

Dick Vitale Receives Jimmy V Award, Cancer Survivor Will Use Golf Scholarship to Study Medicine and More

July 22nd 2022, 3:00pm

Article

From Dick Vitale receiving the Jimmy V Award at the 2022 ESPYs to a former triathlon champion opening up about his cancer experience, here’s what’s happening in the cancer space this week.

FDA to Speed Up Review of Novel CAR-T Cell Therapy for Rare Forms of Lymphoma and Leukemia

July 19th 2022, 9:00pm

Article

A first-in-human trial is investigating the safety and efficacy of the novel CAR-T cell therapy in patients relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.

Adherence to Follow-up Care in Childhood Cancer Survivors Continues to be Subpar, Highlighting Need for More Resources to Increase Engagement

June 29th 2022, 3:00pm

Article

Findings from several studies have shown that childhood cancer survivors often stop attending much needed follow-up visits in the years following treatment.

FDA Approves Tafinlar Plus Mekinist for Patients With BRAF V600-Mutant Solid Cancers

June 23rd 2022, 1:27pm

Article

Tafinlar plus Mekinist is now approved by the Food and Drug Administration to treat adults and children over the age of 6 who have BRAF V600-mutant advanced solid cancers.

Actress Alicia Witt Discusses Cancer Treatment After Losing Her Parents, Chef Gordon Ramsay Surprises a Teen With Cancer and More

June 3rd 2022, 3:00pm

Article

From chef Gordon Ramsay sharing a meal with a 13-year-old fan with Ewing sarcoma, to a dermatologist on a playground spotting a mother’s skin cancer, here’s a look at what’s happening in the cancer space this week.

FDA Will Expedite Review of Omblastys to Treat Metastatic, Pediatric Neuroblastoma

June 2nd 2022, 3:00pm

Article

If approved, Omblastys will be the first FDA-approved drug for children with neuroblastoma that has spread to the central nervous system or leptomeninges.

Hispanic Children With Neuroblastoma Have Poorer Trial Outcomes: Describing Disparities Is ‘Simply Not Enough’

June 1st 2022, 3:00pm

Article

Research showed that Hispanic children with neuroblastoma who are participating on clinical trials tended to have worse survival outcomes than others.

FDA Approves Vidaza for Rare Pediatric Blood Cancer

May 23rd 2022, 3:02pm

Article

The FDA approved Vidaza for the treatment of pediatric patients with juvenile myelomonocytic leukemia.

x